Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoglossal Nerve | 12 | 2024 | 108 | 3.990 |
Why?
|
| Sleep Apnea, Obstructive | 18 | 2024 | 1875 | 3.740 |
Why?
|
| Electric Stimulation Therapy | 8 | 2024 | 628 | 2.930 |
Why?
|
| Endoscopy | 6 | 2024 | 1851 | 0.940 |
Why?
|
| Paranasal Sinuses | 2 | 2017 | 265 | 0.920 |
Why?
|
| Polysomnography | 9 | 2024 | 1848 | 0.900 |
Why?
|
| Snoring | 1 | 2023 | 209 | 0.750 |
Why?
|
| Tonsillectomy | 1 | 2024 | 278 | 0.740 |
Why?
|
| Middle Ear Ventilation | 2 | 2018 | 101 | 0.690 |
Why?
|
| Otitis Media with Effusion | 2 | 2018 | 115 | 0.650 |
Why?
|
| Numismatics | 1 | 2018 | 16 | 0.630 |
Why?
|
| Epistaxis | 1 | 2019 | 112 | 0.610 |
Why?
|
| Oximetry | 1 | 2020 | 459 | 0.580 |
Why?
|
| Mastoiditis | 1 | 2016 | 37 | 0.550 |
Why?
|
| Mastoid | 1 | 2016 | 100 | 0.540 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2017 | 121 | 0.540 |
Why?
|
| Neck Dissection | 1 | 2018 | 201 | 0.530 |
Why?
|
| Parotid Neoplasms | 1 | 2018 | 157 | 0.530 |
Why?
|
| Airway Obstruction | 1 | 2021 | 661 | 0.510 |
Why?
|
| Perineum | 1 | 2017 | 208 | 0.500 |
Why?
|
| Facial Nerve | 1 | 2018 | 277 | 0.500 |
Why?
|
| Skull Base | 1 | 2018 | 292 | 0.490 |
Why?
|
| Ear Auricle | 1 | 2015 | 31 | 0.490 |
Why?
|
| Otitis Media | 1 | 2017 | 286 | 0.490 |
Why?
|
| Ear Neoplasms | 1 | 2015 | 118 | 0.470 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2022 | 975 | 0.470 |
Why?
|
| Foreign Bodies | 1 | 2018 | 402 | 0.450 |
Why?
|
| Oropharynx | 3 | 2024 | 138 | 0.450 |
Why?
|
| Facial Paralysis | 1 | 2018 | 346 | 0.440 |
Why?
|
| Income | 1 | 2022 | 1877 | 0.440 |
Why?
|
| Community-Acquired Infections | 1 | 2017 | 469 | 0.430 |
Why?
|
| Head and Neck Neoplasms | 2 | 2017 | 2895 | 0.410 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1089 | 0.410 |
Why?
|
| Esophagus | 1 | 2018 | 1033 | 0.400 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2022 | 1118 | 0.400 |
Why?
|
| Sinusitis | 4 | 2016 | 991 | 0.390 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2017 | 4026 | 0.380 |
Why?
|
| Neck | 1 | 2016 | 734 | 0.370 |
Why?
|
| Sleep | 7 | 2024 | 4768 | 0.350 |
Why?
|
| Head | 1 | 2016 | 924 | 0.340 |
Why?
|
| Intensive Care Units | 3 | 2017 | 3744 | 0.320 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 1418 | 0.320 |
Why?
|
| Mortality | 1 | 2020 | 2901 | 0.320 |
Why?
|
| Health Expenditures | 1 | 2021 | 2366 | 0.320 |
Why?
|
| Reoperation | 2 | 2024 | 4303 | 0.310 |
Why?
|
| Epiglottis | 2 | 2024 | 81 | 0.290 |
Why?
|
| Middle Aged | 21 | 2024 | 220917 | 0.260 |
Why?
|
| Postoperative Complications | 2 | 2019 | 15633 | 0.260 |
Why?
|
| Pneumonia | 1 | 2017 | 2143 | 0.250 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2016 | 166 | 0.250 |
Why?
|
| Pennsylvania | 2 | 2016 | 613 | 0.250 |
Why?
|
| Mouth Breathing | 1 | 2024 | 25 | 0.240 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1405 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 20569 | 0.240 |
Why?
|
| Palate | 2 | 2024 | 124 | 0.230 |
Why?
|
| Female | 28 | 2024 | 392688 | 0.230 |
Why?
|
| Male | 28 | 2024 | 360841 | 0.230 |
Why?
|
| Implantable Neurostimulators | 2 | 2024 | 75 | 0.230 |
Why?
|
| Adult | 22 | 2024 | 221200 | 0.220 |
Why?
|
| Humans | 43 | 2024 | 761578 | 0.220 |
Why?
|
| Combined Modality Therapy | 3 | 2024 | 8528 | 0.220 |
Why?
|
| Aryldialkylphosphatase | 1 | 2022 | 64 | 0.210 |
Why?
|
| Deglutition | 1 | 2024 | 208 | 0.210 |
Why?
|
| Tongue | 2 | 2024 | 403 | 0.190 |
Why?
|
| Treatment Outcome | 9 | 2024 | 64684 | 0.190 |
Why?
|
| Preoperative Period | 2 | 2021 | 551 | 0.180 |
Why?
|
| Models, Biological | 1 | 2017 | 9469 | 0.180 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 257 | 0.170 |
Why?
|
| Retrospective Studies | 9 | 2021 | 80646 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 3597 | 0.160 |
Why?
|
| Endopeptidases | 1 | 2023 | 774 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36426 | 0.160 |
Why?
|
| Aged | 12 | 2024 | 169308 | 0.160 |
Why?
|
| Intubation, Intratracheal | 2 | 2016 | 1333 | 0.160 |
Why?
|
| Immunization | 1 | 2023 | 1227 | 0.150 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 58983 | 0.150 |
Why?
|
| Certification | 1 | 2021 | 418 | 0.150 |
Why?
|
| Prospective Studies | 6 | 2023 | 54423 | 0.150 |
Why?
|
| Recurrence | 3 | 2019 | 8466 | 0.140 |
Why?
|
| Prevalence | 3 | 2020 | 15732 | 0.140 |
Why?
|
| Nasal Polyps | 3 | 2013 | 395 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2022 | 1668 | 0.140 |
Why?
|
| Demography | 1 | 2021 | 1648 | 0.130 |
Why?
|
| Employment | 1 | 2022 | 1118 | 0.130 |
Why?
|
| Young Adult | 6 | 2020 | 59254 | 0.120 |
Why?
|
| Neurites | 1 | 2017 | 391 | 0.120 |
Why?
|
| Thyroid Nodule | 1 | 2022 | 764 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2018 | 1574 | 0.120 |
Why?
|
| Ear, Middle | 1 | 2016 | 339 | 0.120 |
Why?
|
| Incidence | 3 | 2017 | 21355 | 0.120 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 526 | 0.110 |
Why?
|
| Otolaryngology | 1 | 2021 | 693 | 0.110 |
Why?
|
| B-Lymphocytes | 2 | 2023 | 4758 | 0.110 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2018 | 464 | 0.110 |
Why?
|
| Adolescent | 7 | 2020 | 88323 | 0.110 |
Why?
|
| United States | 5 | 2022 | 72335 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2020 | 1733 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 1179 | 0.100 |
Why?
|
| Counseling | 1 | 2021 | 1547 | 0.100 |
Why?
|
| Length of Stay | 2 | 2016 | 6426 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15843 | 0.100 |
Why?
|
| Infant | 4 | 2018 | 36193 | 0.100 |
Why?
|
| Observer Variation | 1 | 2018 | 2606 | 0.100 |
Why?
|
| Radiology, Interventional | 1 | 2016 | 476 | 0.100 |
Why?
|
| Age Factors | 3 | 2018 | 18398 | 0.100 |
Why?
|
| Child, Preschool | 4 | 2018 | 42231 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3466 | 0.090 |
Why?
|
| Risk Factors | 5 | 2023 | 74212 | 0.090 |
Why?
|
| Vaccination | 1 | 2023 | 3384 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2017 | 3614 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 29629 | 0.090 |
Why?
|
| Asthma, Aspirin-Induced | 1 | 2013 | 202 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2645 | 0.080 |
Why?
|
| Interleukin-9 | 1 | 2009 | 62 | 0.080 |
Why?
|
| Patient Selection | 1 | 2020 | 4244 | 0.080 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2024 | 575 | 0.080 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 2332 | 0.080 |
Why?
|
| Eosinophils | 1 | 2013 | 950 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2021 | 3242 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2024 | 12059 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2020 | 9646 | 0.070 |
Why?
|
| Rhinitis | 2 | 2013 | 747 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2024 | 22176 | 0.070 |
Why?
|
| Child | 5 | 2022 | 80157 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3205 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2018 | 3551 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 6815 | 0.070 |
Why?
|
| Radiography | 1 | 2018 | 6965 | 0.070 |
Why?
|
| Acute Disease | 1 | 2017 | 7237 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2011 | 560 | 0.070 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2013 | 612 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2008 | 750 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12463 | 0.060 |
Why?
|
| Comorbidity | 1 | 2020 | 10508 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2013 | 3162 | 0.060 |
Why?
|
| Critical Care | 1 | 2017 | 2697 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 1964 | 0.060 |
Why?
|
| Survival Rate | 1 | 2018 | 12725 | 0.060 |
Why?
|
| Airway Resistance | 1 | 2024 | 406 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5336 | 0.050 |
Why?
|
| Palate, Hard | 1 | 2023 | 58 | 0.050 |
Why?
|
| Palate, Soft | 1 | 2023 | 100 | 0.050 |
Why?
|
| Biopsy | 1 | 2015 | 6766 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2018 | 3801 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14665 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 12953 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2008 | 1175 | 0.050 |
Why?
|
| Decision Making | 1 | 2016 | 3929 | 0.050 |
Why?
|
| Pharynx | 1 | 2024 | 432 | 0.050 |
Why?
|
| Aspirin | 1 | 2013 | 3133 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2009 | 2490 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16990 | 0.040 |
Why?
|
| Germinal Center | 1 | 2023 | 380 | 0.040 |
Why?
|
| Cytokines | 2 | 2013 | 7396 | 0.040 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2024 | 452 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2024 | 947 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2023 | 474 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12973 | 0.040 |
Why?
|
| Device Removal | 1 | 2024 | 630 | 0.040 |
Why?
|
| Larynx | 1 | 2024 | 492 | 0.040 |
Why?
|
| Specialty Boards | 1 | 2021 | 235 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26127 | 0.040 |
Why?
|
| Video Recording | 1 | 2024 | 967 | 0.040 |
Why?
|
| Monocytes | 1 | 2008 | 2570 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2024 | 625 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4576 | 0.040 |
Why?
|
| Antigens | 1 | 2023 | 1443 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 39970 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 4369 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26198 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 13367 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 7593 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 81539 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 2057 | 0.020 |
Why?
|
| Parotid Gland | 1 | 2013 | 175 | 0.020 |
Why?
|
| Leukotrienes | 1 | 2013 | 231 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 11904 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 290 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 10194 | 0.020 |
Why?
|
| Logistic Models | 1 | 2024 | 13255 | 0.020 |
Why?
|
| Cough | 1 | 2013 | 594 | 0.020 |
Why?
|
| Animals | 2 | 2023 | 168475 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2013 | 463 | 0.020 |
Why?
|
| Cysteine | 1 | 2013 | 891 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2013 | 1814 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 15936 | 0.020 |
Why?
|
| Immunomagnetic Separation | 1 | 2008 | 79 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2009 | 740 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5790 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2013 | 1271 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 1626 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2013 | 9319 | 0.020 |
Why?
|
| Affect | 1 | 2013 | 1486 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2011 | 12794 | 0.010 |
Why?
|
| Sex Factors | 1 | 2018 | 10554 | 0.010 |
Why?
|
| Mast Cells | 1 | 2011 | 1392 | 0.010 |
Why?
|
| Reference Values | 1 | 2011 | 4920 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7391 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6534 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4243 | 0.010 |
Why?
|
| Alleles | 1 | 2009 | 6864 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11076 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 30054 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5485 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23996 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13510 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41493 | 0.010 |
Why?
|
| Asthma | 1 | 2013 | 6234 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 18966 | 0.010 |
Why?
|
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_